kr
78.50
May 31
Business Description
Aker BioMarine ASA
ISIN : NO0010886625
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 1.14 | |||||
Debt-to-EBITDA | 6.89 | |||||
Interest Coverage | 0.17 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.18 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.8 | |||||
3-Year EBITDA Growth Rate | -7.5 | |||||
3-Year EPS without NRI Growth Rate | -27 | |||||
3-Year FCF Growth Rate | 69.8 | |||||
3-Year Book Growth Rate | 5.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.77 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.45 | |||||
9-Day RSI | 71.55 | |||||
14-Day RSI | 68.19 | |||||
6-1 Month Momentum % | 66.35 | |||||
12-1 Month Momentum % | 100.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.54 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 292.4 | |||||
Days Sales Outstanding | 80.78 | |||||
Days Payable | 70.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -6.65 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.23 | |||||
Operating Margin % | 1.6 | |||||
Net Margin % | -0.98 | |||||
FCF Margin % | 1.5 | |||||
ROE % | -0.95 | |||||
ROA % | -0.41 | |||||
ROIC % | 0.09 | |||||
ROC (Joel Greenblatt) % | 0.65 | |||||
ROCE % | 0.51 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 151.84 | |||||
Forward PE Ratio | 23.58 | |||||
PE Ratio without NRI | 151.84 | |||||
Price-to-Owner-Earnings | 114.26 | |||||
PEG Ratio | 14.46 | |||||
PS Ratio | 2.05 | |||||
PB Ratio | 1.83 | |||||
Price-to-Tangible-Book | 3.22 | |||||
Price-to-Operating-Cash-Flow | 18.86 | |||||
EV-to-EBIT | 277.94 | |||||
EV-to-Forward-EBIT | 16.22 | |||||
EV-to-EBITDA | 17.39 | |||||
EV-to-Forward-EBITDA | 9.23 | |||||
EV-to-Revenue | 2.94 | |||||
EV-to-Forward-Revenue | 2.57 | |||||
EV-to-FCF | 195.78 | |||||
Price-to-Graham-Number | 4.66 | |||||
Earnings Yield (Greenblatt) % | 0.36 | |||||
FCF Yield % | 0.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aker BioMarine ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 3,676.59 | ||
EPS (TTM) (kr) | 0.517 | ||
Beta | 0.51 | ||
Volatility % | 39.67 | ||
14-Day RSI | 68.19 | ||
14-Day ATR (kr) | 2.941522 | ||
20-Day SMA (kr) | 73.495 | ||
12-1 Month Momentum % | 100.29 | ||
52-Week Range (kr) | 30.35 - 80 | ||
Shares Outstanding (Mil) | 87.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aker BioMarine ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aker BioMarine ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Aker BioMarine ASA Frequently Asked Questions
What is Aker BioMarine ASA(OSL:AKBM)'s stock price today?
When is next earnings date of Aker BioMarine ASA(OSL:AKBM)?
Does Aker BioMarine ASA(OSL:AKBM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |